The role of specific pancreatic antibodies in the differential diagnosis of complete clinical and laboratory remission of type 1 diabetes mellitus and MODY in children
BACKGROUND: T1D is characterized by autoimmune destruction of pancreatic β-cells, which develops due to genetic and environmental risk factors. Shortly after initiating the treatment with insulin, 80% of children with T1D may require smaller doses of insulin and develop clinical and laboratory remis...
Main Authors: | E. A. Sechko, E. M. Romanenkova, I. A. Eremina, L. I. Zilberman, L. V. Nikankina, Z. T. Zuraeva, O. B. Bezlepkina, V. A. Peterkova, D. N. Laptev |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2022-12-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/12921 |
Similar Items
-
Clinical prediction model for MODY type diabetes mellitus in children
by: D. N. Laptev, et al.
Published: (2024-03-01) -
C-peptide levels and the prevalence of islets autoantibodies in children with type 1 diabetes mellitus with different duration of the disease
by: E. M. Romanenkova, et al.
Published: (2022-05-01) -
Non-immune diabetes mellitus in children due to heterozygous mutations in the glucokinase gene (GCK-MODY): data of 144 patients
by: E. A. Sechko, et al.
Published: (2022-05-01) -
Islet autoantibodies and residual beta-cell function in children with type 1 diabetes depending on age of manifestation
by: E. M. Romanenkova, et al.
Published: (2023-07-01) -
MODY caused by a mutation in the insulin gene
by: E. A. Sechko, et al.
Published: (2022-03-01)